Vaxcyte, Inc. financial data

Symbol
PCVX on Nasdaq
Location
825 Industrial Road, Ste. 300, San Carlos, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.18K % -17.8%
Debt-to-equity 7.19 % +19.7%
Return On Equity -21.1 % +10.4%
Return On Assets -19.7 % +11.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131M shares +5.03%
Common Stock, Shares, Outstanding 130M shares +4.5%
Entity Public Float 7.2B USD +75.6%
Common Stock, Value, Issued 133K USD +4.72%
Weighted Average Number of Shares Outstanding, Basic 136M shares +10.1%
Weighted Average Number of Shares Outstanding, Diluted 136M shares +10.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 686M USD +53.4%
General and Administrative Expense 126M USD +53.5%
Operating Income (Loss) -812M USD -34.4%
Nonoperating Income (Expense) 29.6M USD -19.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -657M USD -29.5%
Earnings Per Share, Basic -4 USD/shares -4.99%
Earnings Per Share, Diluted -4 USD/shares -4.99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 281M USD -73.2%
Other Assets, Current 4.46M USD +111%
Assets, Current 1.77B USD -20.2%
Property, Plant and Equipment, Net 253M USD +55.3%
Operating Lease, Right-of-Use Asset 83.5M USD +191%
Other Assets, Noncurrent 107M USD +77.7%
Assets 3.17B USD -10.9%
Accounts Payable, Current 49M USD +169%
Employee-related Liabilities, Current 16.8M USD +36.9%
Accrued Liabilities, Current 24.6M USD -20%
Liabilities, Current 200M USD +61.6%
Operating Lease, Liability, Noncurrent 78.7M USD +329%
Other Liabilities, Noncurrent 100K USD
Liabilities 279M USD +96.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 856K USD +516%
Retained Earnings (Accumulated Deficit) -1.91B USD -52.5%
Stockholders' Equity Attributable to Parent 2.89B USD -15.4%
Liabilities and Equity 3.17B USD -10.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -166M USD -4.49%
Net Cash Provided by (Used in) Financing Activities 759K USD -99.9%
Net Cash Provided by (Used in) Investing Activities 123M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 130M shares +4.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -41M USD -119%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 283M USD -73.1%
Deferred Tax Assets, Valuation Allowance 446M USD +54.8%
Deferred Tax Assets, Gross 468M USD +57.4%
Operating Lease, Liability 84.4M USD +202%
Payments to Acquire Property, Plant, and Equipment 5.42M USD -4.47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -656M USD -29.9%
Lessee, Operating Lease, Liability, to be Paid 118M USD +243%
Property, Plant and Equipment, Gross 214M USD +141%
Operating Lease, Liability, Current 5.77M USD -40.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.8M USD +154%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.9M USD -5.28%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33.6M USD +420%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.8M USD +296%
Deferred Tax Assets, Operating Loss Carryforwards 196M USD +44.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.53M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.2M USD +296%
Operating Lease, Payments 12.4M USD +15.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.96M USD +196%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%